WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76
3,66
EUR
+0,97 % +0,04
16:14:09 Uhr,
Lang & Schwarz
Kommentare 809
Summer.76,
07.12.2022 23:11 Uhr
0
Kehrtwende bei Morgan Stanley
Peking lockert – Bei diesen China-Aktien sind Analysten bullish
https://www.wallstreet-online.de/_amp/nachricht/16297728-kehrtwende-morgan-stanley-peking-lockert-china-aktien-analysten-bullish
Summer.76,
07.12.2022 23:11 Uhr
0
https://endpts.com/big-pharmas-team-up-with-local-singapore-organizations-to-boost-manufacturing/
Summer.76,
07.12.2022 23:11 Uhr
0
Capital Group: Was hilft gegen die aktuelle Schwäche chinesischer Gesundheitsaktien?
https://www.fundresearch.de/amp/capital-group-was-hilft-gegen-die-aktuelle-schwaeche-chinesischer-gesundheitsaktien-454222
Summer.76,
01.12.2022 6:17 Uhr
0
https://finance.sina.cn/hkstock/ggpj/2022-12-01/detail-imqmmthc6637583.d.html?from=wap
CITIC Securities: WuXi Biologics (02269) was first given a "buy" rating with a target price of HK$67
Summer.76,
29.11.2022 6:57 Uhr
0
http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1229708/2
Summer.76,
28.11.2022 17:22 Uhr
0
WuXi Biologics (02269) granted approximately 7.331 million shares under the restricted share award plan
https://finance.sina.cn/hkstock/gsxw/2022-11-28/detail-imqqsmrp7871550.d.html?from=wap
Summer.76,
21.11.2022 13:35 Uhr
0
WuXi Biologics Launches an Integrated Biologics CRDMO Center in Fengxian, Shanghai
https://www.prnewswire.com/news-releases/wuxi-biologics-launches-an-integrated-biologics-crdmo-center-in-fengxian-shanghai-301683701.html
Summer.76,
14.11.2022 18:54 Uhr
0
"Research Report" Morgan Stanley lists the list of stocks benefiting from China's "re-clearance" theme
http://www.aastocks.com/tc/stocks/news/aafn-news/NOW.1226228/3
Morgan Stanley released the 2023 China Capital Market Strategy Report, stating that it listed a list of stocks that benefited from China's "reopening" theme:
Stocks to see:
...
WUXI BIO
...
D
Summer.76,
27.10.2022 19:16 Uhr
0
WuXi Biologics Provides Corporate Updates
https://www.prnewswire.com/news-releases/wuxi-biologics-provides-corporate-updates-301661384.html
Summer.76,
26.10.2022 12:20 Uhr
0
https://www.prnewswire.com/news-releases/wuxi-biologics-announces-gmp-release-of-48-000l-commercial-drug-substance-manufacturing-facility-in-hebei-china-301659418.html
Summer.76,
25.10.2022 6:15 Uhr
0
WUXI BIO Buys back 4M Shrs for $156M
http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1221334/company-news/HK6
Summer.76,
25.10.2022 6:14 Uhr
0
http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1221086/company-news/HK6
WUXI BIO Buys back 5M Shrs for $213M Last Fri
Summer.76,
24.10.2022 6:33 Uhr
0
https://m.hkej.com/landing/mobarticle2?id=3279793
The list of the new Standing Committee of the Political Bureau of the Central Committee of the Communist Party of China has been announced, and the central economic decision-making team is expected to be restructured. The market is concerned about the impact on the Greater China stock market. ...
Meistdiskutiert
|
|
Thema | ||
|---|---|---|---|
| 1 | für alle, die es ehrlich meinen beim Traden. | ||
| 2 | NVIDIA Hauptdiskussion | -1,36 % | |
| 3 | Diginex | -2,31 % | |
| 4 | DAX Hauptdiskussion | -0,35 % | |
| 5 | Beyond Meat Hauptdiskussion | +0,61 % | |
| 6 | Critical Metals: Grönland - Tanbreez seltene Erden | -7,79 % | |
| 7 | EUROPEAN LITHIUM Hauptdiskussion | +40,13 % | |
| 8 | TUI Hauptforum | -0,95 % | |
| 9 | AMD Hauptdiskussion | -2,69 % | |
| 10 | Security der nächsten Generation | -4,39 % | Alle Diskussionen |
Aktien
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | -1,36 % | |
| 2 | Diginex | -2,31 % | |
| 3 | Beyond Meat Hauptdiskussion | +0,63 % | |
| 4 | Critical Metals: Grönland - Tanbreez seltene Erden | -6,29 % | |
| 5 | EUROPEAN LITHIUM Hauptdiskussion | +39,56 % | |
| 6 | AMD Hauptdiskussion | -2,63 % | |
| 7 | TUI Hauptforum | -0,76 % | |
| 8 | Security der nächsten Generation | -3,86 % | |
| 9 | ALEXANDRIA REAL EST. EQU. Hauptdiskussion | -10,85 % | |
| 10 | Ecograf - ein Stern am Graphithimmel | -11,91 % | Alle Diskussionen |